ESTRO 2024 - Abstract Book

S1794

Clinical - Lung

ESTRO 2024

Figure 2 Radiographic and clinical toxicities related to SABR.

Conclusion:

Our data confirms that SABR is safe and effective treatment method also for very elderly patients with ES-NSCLC. This analysis corroborates the excellent safety profile of SABR in light of the very low rates of clinical-radiological pulmonary toxicity events. Patients with better pretreatment pulmonary function tests (FEV1 ≥ 90%) and PTV ≤ 35cc seems to derive the most benefit from treatment.

Keywords: Elderly, SABR, ES-NSCLC

References:

1. Ronden MI, Palma D, Slotman BJ, Senan S, Advanced Radiation Technology Committee of the International Association for the Study of Lung Cancer. Brief Report on Radiological Changes following Stereotactic Ablative